Home › Cancer Genetics Q4 Revenues Up 32 Percent

Cancer Genetics Q4 Revenues Up 32 Percent

Mar 23, 2017

NEW YORK (GenomeWeb) – Cancer Genetics reported today that its fourth quarter revenues grew 32 percent year over year.

For the three months ended Dec. 31, 2016, the company reported revenues of $7.2 million up from $5.5 million in Q4 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Cancer

  1. Cancer Genetics Cancels Planned Merger With NovellusDx

  2. Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

    Premium

  3. Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs

  4. Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers

  5. Colon Cancer Test Distribution Deals Inked by HalioDx

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.